Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.67B | 2.35B | 2.09B | 1.87B | 1.71B |
Gross Profit | 1.41B | 1.32B | 1.20B | 1.10B | 991.84M |
EBITDA | 1.86B | 1.70B | 1.50B | 1.36B | 1.19B |
Net Income | 907.19M | 905.37M | 846.83M | 787.73M | 783.25M |
Balance Sheet | |||||
Total Assets | 24.07B | 20.78B | 18.14B | 16.47B | 15.18B |
Cash, Cash Equivalents and Short-Term Investments | 498.74M | 237.28M | 309.67M | 387.32M | 401.95M |
Total Debt | 16.60B | 13.75B | 11.90B | 10.57B | 9.12B |
Total Liabilities | 18.95B | 16.12B | 13.55B | 12.02B | 10.86B |
Stockholders Equity | 5.12B | 4.65B | 4.58B | 4.44B | 4.31B |
Cash Flow | |||||
Free Cash Flow | -1.39B | -472.33M | -415.25M | -552.28M | 238.77M |
Operating Cash Flow | 1.59B | 1.47B | 1.33B | 1.27B | 1.18B |
Investing Cash Flow | -2.96B | -1.94B | -1.74B | -1.82B | -1.38B |
Financing Cash Flow | 1.64B | 394.31M | 336.67M | 536.78M | 140.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | HK$19.89B | 12.36 | 16.04% | 0.13% | 6.53% | 4.78% | |
76 Outperform | €18.79B | 19.48 | 19.23% | 1.41% | 12.91% | 5.31% | |
73 Outperform | HK$15.35B | 20.61 | 8.94% | 2.67% | 1.01% | 12.45% | |
68 Neutral | $23.00B | 11.72 | 4.96% | 0.33% | 1.31% | 379.84% | |
66 Neutral | HK$27.51B | 22.27 | 6.76% | 4.83% | 7.13% | -42.14% | |
58 Neutral | HK$8.86B | 8.01 | 2935.68% | ― | 0.27% | -35.07% | |
54 Neutral | $1.23B | 3.75 | 0.67% | 6.15% | -2.39% | -129.28% |
SUNeVision Holdings Ltd. announced the grant of 21,790,000 share options to certain individuals under its share option scheme adopted in November 2022. This move is part of the company’s strategy to incentivize its directors, employees, and related entity participants, potentially enhancing their commitment and aligning their interests with the company’s growth objectives. The share options have a five-year exercise period with a structured vesting schedule, which could impact the company’s operational dynamics by fostering long-term engagement among key stakeholders.
The most recent analyst rating on (HK:1686) stock is a Buy with a HK$4.60 price target. To see the full list of analyst forecasts on Sunevision Holdings Ltd. stock, see the HK:1686 Stock Forecast page.